15,25,35-tris(1,2,3,3a,4,5,6,7,8,8a-decahydroazulen-2-yl)-18,32-bis(2,6-difluorophenyl)-12,38-diphenyl-22,28-dioxa-12,18,32,38-tetraza-1,5,45-triboratridecacyclo[25.21.1.15,13.133,37.02,21.04,19.06,11.023,49.029,48.031,46.039,44.017,51.045,50]henpentaconta-2(21),3,6,8,10,13(51),14,16,19,23,25,27(49),29(48),30,33,35,37(50),39,41,43,46-henicosaene
C96H85B3F4N4O2 — CID 162714561
Data last refreshed: (MolForge compound catalog, from PubChem)
About 15,25,35-tris(1,2,3,3a,4,5,6,7,8,8a-decahydroazulen-2-yl)-18,32-bis(2,6-difluorophenyl)-12,38-diphenyl-22,28-dioxa-12,18,32,38-tetraza-1,5,45-triboratridecacyclo[25.21.1.15,13.133,37.02,21.04,19.06,11.023,49.029,48.031,46.039,44.017,51.045,50]henpentaconta-2(21),3,6,8,10,13(51),14,16,19,23,25,27(49),29(48),30,33,35,37(50),39,41,43,46-henicosaene
15,25,35-tris(1,2,3,3a,4,5,6,7,8,8a-decahydroazulen-2-yl)-18,32-bis(2,6-difluorophenyl)-12,38-diphenyl-22,28-dioxa-12,18,32,38-tetraza-1,5,45-triboratridecacyclo[25.21.1.15,13.133,37.02,21.04,19.06,11.023,49.029,48.031,46.039,44.017,51.045,50]henpentaconta-2(21),3,6,8,10,13(51),14,16,19,23,25,27(49),29(48),30,33,35,37(50),39,41,43,46-henicosaene (PubChem CID 162714561) has the molecular formula C96H85B3F4N4O2 and a molecular weight of 1435.19 g/mol. Its IUPAC name is 15,25,35-tris(1,2,3,3a,4,5,6,7,8,8a-decahydroazulen-2-yl)-18,32-bis(2,6-difluorophenyl)-12,38-diphenyl-22,28-dioxa-12,18,32,38-tetraza-1,5,45-triboratridecacyclo[25.21.1.15,13.133,37.02,21.04,19.06,11.023,49.029,48.031,46.039,44.017,51.045,50]henpentaconta-2(21),3,6,8,10,13(51),14,16,19,23,25,27(49),29(48),30,33,35,37(50),39,41,43,46-henicosaene.
Molecular Properties
| Compound Name | 15,25,35-tris(1,2,3,3a,4,5,6,7,8,8a-decahydroazulen-2-yl)-18,32-bis(2,6-difluorophenyl)-12,38-diphenyl-22,28-dioxa-12,18,32,38-tetraza-1,5,45-triboratridecacyclo[25.21.1.15,13.133,37.02,21.04,19.06,11.023,49.029,48.031,46.039,44.017,51.045,50]henpentaconta-2(21),3,6,8,10,13(51),14,16,19,23,25,27(49),29(48),30,33,35,37(50),39,41,43,46-henicosaene |
|---|---|
| PubChem CID | 162714561 |
| Molecular Formula | C96H85B3F4N4O2 |
| Molecular Weight | 1435.19 g/mol |
| Exact Mass | 1434.69 |
| IUPAC Name | 15,25,35-tris(1,2,3,3a,4,5,6,7,8,8a-decahydroazulen-2-yl)-18,32-bis(2,6-difluorophenyl)-12,38-diphenyl-22,28-dioxa-12,18,32,38-tetraza-1,5,45-triboratridecacyclo[25.21.1.15,13.133,37.02,21.04,19.06,11.023,49.029,48.031,46.039,44.017,51.045,50]henpentaconta-2(21),3,6,8,10,13(51),14,16,19,23,25,27(49),29(48),30,33,35,37(50),39,41,43,46-henicosaene |
| SMILES | Fc1cccc(F)c1N1c2cc3c(cc2B2c4ccccc4N(c4ccccc4)c4cc(C5CC6CCCCCC6C5)cc1c42)B1c2cc4c(cc2Oc2cc(C5CC6CCCCCC6C5)cc(c21)O3)N(c1c(F)cccc1F)c1cc(C2CC3CCCCCC3C2)cc2c1B4c1ccccc1N2c1ccccc1 |
| InChI | InChI=1S/C96H85B3F4N4O2/c100-76-34-20-35-77(101)95(76)106-82-54-88-74(52-72(82)97-70-32-16-18-38-80(70)104(68-28-12-4-13-29-68)84-46-65(48-86(106)92(84)97)62-40-56-22-6-1-7-23-57(56)41-62)99-75-53-73-83(55-89(75)109-91-51-67(50-90(108-88)94(91)99)64-44-60-26-10-3-11-27-61(60)45-64)107(96-78(102)36-21-37-79(96)103)87-49-66(63-42-58-24-8-2-9-25-59(58)43-63)47-85-93(87)98(73)71-33-17-19-39-81(71)105(85)69-30-14-5-15-31-69/h4-5,12-21,28-39,46-64H,1-3,6-11,22-27,40-45H2 |
| InChIKey | WDTHYHZRADGPLW-UHFFFAOYSA-N |
| XLogP | 20.36 |
| TPSA | 31.42 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 109 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1435.19 |
| LogP ≤ 5 | 20.36 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162714561 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.